Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Inscripta, Inc
Private Company Edition: Clover’s $230m financing was the largest of recent mega-rounds. Century Therapeutics ($160m), Vividion ($135m) and eGenesis ($125m) also raised big rounds and investors Foresite Capital ($969m), Sofinnova Partners ($540m) and OMX Ventures ($150m) raised new VC funds.
- Research, Analytical Equipment & Supplies
- Antisense, Oligonucleotides
Drug Discovery Tools
- Molecular Diversity
- Other Names / Subsidiaries
- Muse Biotechnology Inc.